Jacob Chacko

Insider Reports History

Entity
Individual
Location
C/O Ignyta, Inc., 11095 Flintkote Ave., Suite D, San Diego, CA
Signature
By: /s/ Scott Bizily as Attorney-in-fact for Jacob Chacko
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jacob Chacko:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oric Pharmaceuticals, Inc. PRESIDENT AND CEO, Director Common Stock 729K $11.8M $16.21 Mar 6, 2024 Direct
Oric Pharmaceuticals, Inc. PRESIDENT AND CEO, Director Restricted Stock Unit 85K $730K $8.59 Jan 2, 2024 Direct
Oric Pharmaceuticals, Inc. PRESIDENT AND CEO, Director Stock Option (right to buy) 510K Jan 2, 2024 Direct
4D Molecular Therapeutics, Inc. Director Stock Option (Right To Buy) 22.5K May 21, 2024 Direct

Insider Reports Filed by Jacob Chacko

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FDMT 4D Molecular Therapeutics, Inc. May 21, 2024 1 $0 4 May 23, 2024 Director
ORIC Oric Pharmaceuticals, Inc. Mar 6, 2024 1 -$648K 4 Mar 8, 2024 PRESIDENT AND CEO, Director
ORIC Oric Pharmaceuticals, Inc. Feb 6, 2024 2 -$489K 4 Feb 8, 2024 PRESIDENT AND CEO, Director
ORIC Oric Pharmaceuticals, Inc. Jan 2, 2024 2 $0 4 Jan 3, 2024 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. Dec 15, 2023 4 -$125K 4 Dec 19, 2023 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. Jul 10, 2023 2 -$125K 4 Jul 11, 2023 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. Jul 5, 2023 1 -$34.7K 4 Jul 7, 2023 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. Jun 26, 2023 1 -$161K 4 Jun 28, 2023 President and CEO, Director
FDMT 4D Molecular Therapeutics, Inc. May 23, 2023 1 $0 4 May 25, 2023 Director
FDMT 4D Molecular Therapeutics, Inc. Apr 21, 2023 3 -$53.2K 4 Apr 25, 2023 Director
ORIC Oric Pharmaceuticals, Inc. Feb 1, 2023 2 $0 4 Feb 2, 2023 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. Dec 15, 2022 1 -$18.9K 4/A Feb 17, 2023 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. Jul 20, 2022 6 $0 4 Jul 21, 2022 President and CEO, Director
FDMT 4D Molecular Therapeutics, Inc. May 23, 2022 1 $0 4 May 25, 2022 Director
ORIC Oric Pharmaceuticals, Inc. May 11, 2022 3 $1.29M 4 May 13, 2022 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. Mar 23, 2022 3 $1.72M 4 Mar 25, 2022 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. Feb 1, 2022 2 $0 4 Feb 2, 2022 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. Sep 14, 2021 2 -$204K 4 Sep 16, 2021 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. Sep 10, 2021 2 -$144K 4 Sep 14, 2021 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. Sep 7, 2021 2 -$155K 4 Sep 9, 2021 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. May 27, 2021 1 -$10K 4 May 28, 2021 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. May 20, 2021 3 -$183K 4 May 24, 2021 President and CEO, Director
FDMT 4D Molecular Therapeutics Inc. May 17, 2021 1 $0 4 May 19, 2021 Director
ORIC Oric Pharmaceuticals, Inc. May 14, 2021 4 -$704K 4 May 18, 2021 President and CEO, Director
ORIC Oric Pharmaceuticals, Inc. May 11, 2021 3 -$55.8K 4 May 13, 2021 President and CEO, Director